Drug manufacturer Eli Lilly has filed suit against four companies involved in making, prescribing, and/or selling compounded versions of its weight loss and diabetes drugs ZEPBOUND® and MOUNJARO®....more
4/30/2025
/ Business Litigation ,
California ,
Corporate Practice of Medicine ,
Enforcement Actions ,
Life Sciences ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Legislation ,
State Legislatures ,
Telehealth ,
Unfair Competition
On March 13, 2024, Indiana Governor Eric J. Holcomb signed Senate Enrolled Act No. 9 (“SEA 9”) which will amend the Indiana Code with respect to notice of health care entity mergers and acquisitions....more
3/22/2024
/ Acquisition Agreements ,
Amended Regulation ,
Corporate Sales Transactions ,
Healthcare ,
Healthcare Facilities ,
Hospital Mergers ,
Life Sciences ,
Merger Agreements ,
Notice Requirements ,
Private Equity ,
Regulatory Requirements